Source: FierceBiotech Dermatology player Arcutis Biotherapeutics set up shop in 2016 but stayed under the radar until early last year.…...
Latest News
Fortress Biotech Ranked in Top 10 of Deloitte’s 2019 Technology Fast 500™
Source: BioSpace Fortress Biotech, Inc. (Nasdaq: FBIO) (“Fortress”), an innovative biopharmaceutical company focused on identifying, in-licensing and developing high-potential marketed…...
"I cannot say enough great things about Angel and my experience with her and QFR Solutions. From the time she…...
Stryker to buy orthopedic device maker Wright Medical for $4B
Source: FierceBiotech Stryker is moving to acquire fellow devicemaker Wright Medical in a $4 billion play to gain a stronger…...
UCB strikes $2.5B deal to buy Ra for rival to Alexion’s Soliris
Source: FierceBiotech UCB Pharma has struck a $2.5 billion (€2.2 billion) deal to acquire Ra Pharmaceuticals. The takeover will give UCB control…...
Cassiopea Anounces FDA Submission of New Drug Application for Clascoterone Cream 1%, The First New Mechanism of Action for Acne in Nearly 40 Years
Source: Cassiopea Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action…...
AbbVie Looks Beyond Humira with $63 Billion Deal for Botox-Maker Allergan
Source: Reuters Drugmaker AbbVie Inc said on Tuesday it would buy Botox-maker Allergan Plc for about $63 billion, grabbing control…...
Pharma Celgene, Say Goodbye to Otezla: BMS Agrees to Sell Psoriasis Drug to Clear $74B Merger
Source: FiercePharma With the Federal Trade Commission (FTC) sweating the details of Bristol-Myers Squibb and Celgene’s proposed $74 billion merger,…...
Bellus Medical, the Aesthetics Division of Crown Laboratories, Announces Acquisition of Healeon Medical’s HD PRP System for Aesthetic Marketplace
Source: PRNewswire DALLAS, May 23, 2019 /PRNewswire/ -- Bellus Medical is proud to announce the acquisition of Healeon Medical, Inc.'s HD PRP system for…...
Encore Dermatology Inc. Acquires SERNIVO®, TRIANEX® and PROMISEB®
Source: BusinessWire MALVERN, Pa.--(BUSINESS WIRE)--Encore Dermatology Inc. announced today that it has acquired rights for SERNIVO® (betamethasone dipropionate) Spray, 0.05%,…...